BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 10458011)

  • 21. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.
    Deraco M; Kusamura S; Laterza B; Favaro M; Fumagalli L; Costanzo P; Baratti D
    In Vivo; 2006; 20(6A):773-6. PubMed ID: 17203766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.
    Saxena A; Yan TD; Chua TC; Morris DL
    Ann Surg Oncol; 2010 May; 17(5):1291-301. PubMed ID: 20039212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
    Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
    Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience of pseudomyxoma peritonei in Taiwan with emphasis on the treatment and survival.
    Huang HC; Huang YS; Shyr YM; Yen SH; Chang FY; Lee SD
    Hepatogastroenterology; 2002; 49(46):999-1001. PubMed ID: 12143263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intraoperative (hyperthermic) intraperitoneal chemotherapy--considerations and aspects of safe intra- and postoperative treatment with cytostatic drugs].
    Jähne J; Piso P; Schmoll E; Haulitschek-Hauss R; Sterzenbach H; Paul H; Pichlmayr R
    Langenbecks Arch Chir; 1997; 382(1):8-14. PubMed ID: 9157234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Elias D; Honoré C; Ciuchendéa R; Billard V; Raynard B; Lo Dico R; Dromain C; Duvillard P; Goéré D
    Br J Surg; 2008 Sep; 95(9):1164-71. PubMed ID: 18690633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of pseudomyxoma peritonei successfully treated with multidisciplinary treatment including modified FOLFOX6 regimen].
    Ishibashi K; Sobajima J; Okada N; Ishizuka N; Yokoyama M; Mitsuhashi T; Miyazaki T; Nakada H; Gonda T; Ishida H
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):2047-9. PubMed ID: 18219894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
    Sugarbaker PH
    J Surg Oncol; 2005 Nov; 92(2):142-6. PubMed ID: 16231365
    [No Abstract]   [Full Text] [Related]  

  • 30. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.
    Smeenk RM; van Velthuysen ML; Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2008 Feb; 34(2):196-201. PubMed ID: 17524597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten years experience in the treatment of pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion.
    De Simone M; Vaira M; Caponi A; Ciaccio B; Fiorentini G; Turrisi G; Ferri L; Buti G
    In Vivo; 2006; 20(6A):725-7. PubMed ID: 17203755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and therapeutic considerations in pseudomyxoma peritonei].
    Constantinoiu S; Chiru F; Mateş IN; Pop D; Cochior D; Bârlă R; Dinu D; Predescu D; Predescu V
    Chirurgia (Bucur); 1998; 93(1):27-37. PubMed ID: 9567459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
    Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomyxoma peritonei: a clinicopathologic analysis and follow-up of 21 patients.
    Varona JF; Guerra JM; Salamanca J; Colina F; Lopez G; Morales M
    Hepatogastroenterology; 2005; 52(63):812-6. PubMed ID: 15966210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.
    Smeenk RM; Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2006 Mar; 32(2):186-90. PubMed ID: 16303281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
    Prayson RA; Hart WR; Petras RE
    Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
    Bjersand K; Mahteme H; Sundström Poromaa I; Andréasson H; Graf W; Larsson R; Nygren P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S810-6. PubMed ID: 26193962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin.
    Tan GH; Novo CA; Dayal S; Chandrakumaran K; Mohamed F; Cecil T; Moran BJ
    Eur J Surg Oncol; 2017 Feb; 43(2):388-394. PubMed ID: 27866811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary metastases in pseudomyxoma peritonei syndrome.
    Mortman KD; Sugarbaker PA; Shmookler BM; DeGuzman VC; Soberman MS
    Ann Thorac Surg; 1997 Nov; 64(5):1434-6. PubMed ID: 9386716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.